Company Profile
IRIDEX Stock Price, News & Analysis
- Ticker:
- IRIX
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.84 USD (-0.53%)
Close
Last updated: August 6, 2026
20.4M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, IRIX closed down 0.53% at $0.8396. No new same-company headline was identified in the current news window.
Company overview
Business overview
IRIDEX is a medical device company focused on ophthalmic laser systems and eye-care procedures. Its business is built around retina and glaucoma treatment platforms.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, IRIDEX sits in ophthalmic medtech.
Business Model Characteristics
The company depends on device adoption, surgeon and physician use, and the commercialization of its eye-care systems.
Position Within the Biotechnology Landscape
IRIDEX is a niche eye-care device name whose stock is driven by product execution and procedure demand.
Future catalysts
What matters most for IRIDEX from here is its latest development priorities. That matters because the company is now talking about the next company-specific pipeline update. That is the piece most likely to shape sentiment in the near term.
Recent news
- 01
- 02
- 03
- 04
Iridex Reports First Quarter 2026 Financial Results
Source: IRIDEX
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of IRIDEX (IRIX)?
IRIDEX (IRIX) most recently closed at 0.84 USD, a -0.53% move versus the previous session.
What is the market cap of IRIDEX (IRIX)?
IRIDEX currently has a market capitalization of 20.4M USD on BioPharmSignal.
What does IRIDEX do?
IRIDEX is a medical device company focused on ophthalmic laser systems and eye-care procedures. Its business is built around retina and glaucoma treatment platforms.
On which exchange is IRIX stock listed?
IRIDEX (IRIX) is associated with NASDAQ, United States, Biopharma.
What is What?
What matters most for IRIDEX from here is its latest development priorities.
Which conditions is IRIDEX targeting with What?
What matters most for IRIDEX from here is its latest development priorities.
How does IRIDEX describe recent progress with What?
What matters most for IRIDEX from here is its latest development priorities.
What is That?
That matters because the company is now talking about the next company-specific pipeline update.